title: [Positron emission tomography in the diagnosis of lung cancer].
abstract: BACKGROUND
  Lung cancer is a common malignancy. Positron emission tomography (PET) has become an important tool in the staging of the disease with regard to operability and in order to determine radiation volume when surgery is not indicated.
  
  
  METHODS
  We have assessed and discuss results recently published in major international journals.
  
  
  RESULTS
  In approximately 60% of the patients, the planning of treatment is modified after a PET investigation.
  
  
  CONCLUSIONS
  In contrast to the state the art in most industrialised countries, dedicated PET is not available in Norway. Hence lung cancer is suboptimally treated.
authors.affiliation: Nukleaermedisinsk avdeling, Radiumhospitalet, 0310 Oslo. tore.bach-gansmo@klinmed.uio.no
authors.forename: Tore
authors.initials: T
authors.lastname: Bach-Gansmo
authors.forename: Trond Velde
authors.initials: TV
authors.lastname: Bogsrud
authors.forename: Magne
authors.initials: M
authors.lastname: Aas
authors.forename: Lars H
authors.initials: LH
authors.lastname: Jørgensen
authors.forename: Barbara Malene
authors.initials: BM
authors.lastname: Fischer
mesh_terms: D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging*; D015201:Meta-Analysis as Topic; D016032:Randomized Controlled Trials as Topic; D014055:Tomography, Emission-Computed